These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6896795)
41. Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. Arlin ZA; Flomenberg N; Gee TS; Kempin SJ; Dellaquila C; Mertelsmann R; Straus DJ; Young CW; Clarkson BD Cancer Clin Trials; 1981; 4(3):317-21. PubMed ID: 6895190 [TBL] [Abstract][Full Text] [Related]
42. A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies. Brenner DE; Garbino C; Kasdorf H; Villasanta U; Polcaro R; Yovarone J; Aisner J; Schiffer CA; Wiernik PH Am J Clin Oncol; 1982 Jun; 5(3):291-5. PubMed ID: 6896260 [TBL] [Abstract][Full Text] [Related]
43. Phase II evaluation of AMSA in patients with metastatic lung cancer. Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104 [TBL] [Abstract][Full Text] [Related]
44. Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma. Polyzos A; Legha SS; Burgess AM; Benjamin RS; Bodey GP Invest New Drugs; 1988 Apr; 6(1):57-61. PubMed ID: 3410667 [TBL] [Abstract][Full Text] [Related]
45. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma. Warrell RP; Straus DJ; Young CW Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952 [TBL] [Abstract][Full Text] [Related]
46. A phase I and II study of m-AMSA in acute leukaemia. Slevin ML; Shannon MS; Prentice HG; Goldman AJ; Lister TA Cancer Chemother Pharmacol; 1981; 6(2):137-40. PubMed ID: 6946878 [TBL] [Abstract][Full Text] [Related]
47. m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study. Hilgers RD; Legha SS; Johnston GA; Alberts DS; Stephens RL; Tranum BL; Hannigan EV Invest New Drugs; 1984; 2(3):335-8. PubMed ID: 6548984 [TBL] [Abstract][Full Text] [Related]
48. A phase II trial of m-AMSA in head and neck cancer. Forastiere AA; Young CW; Wittes RE Cancer Chemother Pharmacol; 1981; 6(2):145-6. PubMed ID: 6895486 [TBL] [Abstract][Full Text] [Related]
49. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report. Van Amburg AL; Presant CA; Burns D Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234 [TBL] [Abstract][Full Text] [Related]
50. A phase II trial of m-AMSA in patients with small-cell lung cancer. Natale RB; Gralla RJ; Wittes RE Cancer Clin Trials; 1981; 4(4):393-5. PubMed ID: 6274533 [TBL] [Abstract][Full Text] [Related]
51. Phase II study of AMSA in patients with metastatic malignant melanoma. Houghton AM; Camacho F; Wittes R; Young CW Cancer Treat Rep; 1981; 65(1-2):170-1. PubMed ID: 6894401 [No Abstract] [Full Text] [Related]
52. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia. Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561 [TBL] [Abstract][Full Text] [Related]
53. High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study. Cassileth PA; Lyman GH; Bennett JM; Glick JH; Oken MM Am J Clin Oncol; 1984 Aug; 7(4):361-3. PubMed ID: 6547566 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group study. Krischer J; Land VJ; Civin CI; Ragab AH; Mahoney DH; Frankel LS Cancer; 1984 Jul; 54(2):207-10. PubMed ID: 6586277 [TBL] [Abstract][Full Text] [Related]
55. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers. Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258 [TBL] [Abstract][Full Text] [Related]
56. Phase I and II study of AMSA in childhood tumours. Goldman A; Malpas JS Cancer Chemother Pharmacol; 1982; 9(1):53-6. PubMed ID: 6958393 [TBL] [Abstract][Full Text] [Related]
57. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma. Carroll DS; Kemeny N; Lynch G; Wookcock T Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951 [No Abstract] [Full Text] [Related]
58. Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group. De Jager R; Siegenthaler P; Cavalli F; Klepp O; Bramwell V; Joss R; Alberto P; van Glabbeke M; Renard J; Rozencweig M; Hansen HH Eur J Cancer Clin Oncol; 1983 Feb; 19(2):289-93. PubMed ID: 6687457 [TBL] [Abstract][Full Text] [Related]
59. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma. Sordillo PP; Magill GB; Gralla RJ; Golbey RB Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950 [No Abstract] [Full Text] [Related]
60. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer. Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]